ScreenerHero

0QNO Lonza Group AG

LSE · GB · Healthcare · Biotechnology · lonza.com
588.50CHF+2.45%Mkt Cap: —P/E: 14.89

Lonza Group AG, together with its subsidiaries, operates as a contract development and manufacturing organization for pharma and biotech companies in Europe, North and Central America, Latin America, Asia, Australia, New…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$128.08BUSDP/E 29.4
MRNA
Moderna, Inc.
$78.44BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$76.40BUSDP/E 18.4
ARGX
argenx SE
$57.03BUSDP/E 37.3
ARGX
argenx SE
$58.08BUSDP/E 35.4
UCB
UCB SA
$42.24BUSDP/E 18.0
RVMD
Revolution Medicines, Inc.
$43.05BUSD
ONC
BeOne Medicines AG
$41.41BUSDP/E 65.1
RPRX
Royalty Pharma plc
$32.80BUSDP/E 30.2
ALNY
Alnylam Pharmaceuticals, Inc.
$30.03BUSDP/E 37.8
ROIV
Roivant Sciences Ltd.
$25.10BUSD
BNTX
BioNTech SE
$23.93BUSD
INCY
Incyte Corporation
$22.99BUSDP/E 14.5
GMAB
Genmab A/S
$22.27BUSDP/E 30.7
GMAB
Genmab A/S
$22.54BUSDP/E 28.9
INSM
Insmed Incorporated
$22.22BUSD
ASND
Ascendis Pharma A/S
$15.03BUSDP/E 17.5
JAZZ
Jazz Pharmaceuticals plc
$15.01BUSDP/E 15.8
EXEL
Exelixis, Inc.
$14.48BUSDP/E 18.4
SMMT
Summit Therapeutics Inc.
$14.32BUSD

Key Statistics

Company
Market Cap—
Enterprise Value51.10B USD
Revenue (TTM)7.84B USD
Gross Profit2.91B USD
Net Income (TTM)1.23B USD
Revenue/Share98.33 CHF
Last Price588.50 CHF
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees20.1K
CountryGB
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)14.89
P/E (Forward)—
PEG—
EV/EBITDA18.73
EV/Revenue6.52
P/S—
P/B5.06
EPS (TTM)39.52
EPS (Forward)—
52W Range
455.1096% of range594.20
52W High594.20 CHF
52W Low455.10 CHF
Profitability
Gross Margin37.14%
Oper. Margin23.41%
EBITDA Margin34.78%
Profit Margin-1.60%
ROE12.90%
ROA5.44%
Growth
Revenue Growth11.20%
Earnings Growth39.20%
Cash Flow & Leverage
Operating CF1.64B USD
CapEx (TTM)—
FCF Margin-22.81%
FCF Yield—
Net Debt4.20B USD
Net Debt/EBITDA1.54
Balance Sheet
Debt/Equity51.12
Current Ratio1.66
Quick Ratio0.59
Book Value/Sh116.37 CHF
Cash/Share6.98 CHF
Dividends
Fwd Div Rate—
Trail. Div Rate5.00 CHF
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.74.43M
Float69.74M
Insiders0.09%
Institutions58.83%
Technical
SMA 50424.03 (+38.8%)
SMA 200436.80 (+34.7%)
Beta0.81
S&P 52W Chg15.78%
Avg Vol (30d)21.57K
Avg Vol (10d)76.48K
Technical Indicators
RSI (14)62.0
MACD4.3973
MACD Signal2.0678
MACD Hist.+2.3295
BB Upper594.08 CHF
BB Middle558.99 CHF
BB Lower523.91 CHF
BB Width12.55%
ATR (14)12.92 CHF
Vol Ratio (20d)0.42x